The discovery and structure-activity relationships of nonpeptide, low molecular weight antagonists selective for the endothelin ETB receptor

被引:26
作者
Chan, MF [1 ]
Kois, A [1 ]
Verner, EJ [1 ]
Raju, BG [1 ]
Castillo, RS [1 ]
Wu, CD [1 ]
Okun, I [1 ]
Stavros, FD [1 ]
Balaji, VN [1 ]
机构
[1] ImmunoPharmaceut Inc, San Diego, CA 92127 USA
关键词
receptors; antagonists; endothelin;
D O I
10.1016/S0968-0896(98)80010-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The systematic modification of the ETA selective N-(5-isoxazolyl)benzene-sulfonamide endothelin antagonists to give ETB selective antagonists is reported. The reversal in selectivity was brought about by substitution of the 4-position with aryl and substituted aryl groups. Of all the aromatic substituents studied, the para-tolyl group gave rise to the most active and selective ETB antagonist. Larger substituents caused a decrease in both ETB activity and selectivity. A similar trend was observed by substitution at the 5-position of the N-(5-isoxazolyl)-2-thiophenesulfonamide ETA receptor antagonists. The para-tolyl group was again found to be optimal for the ETB activity and selectivity. The structural features that were found to be favorable for binding to the ETB receptor, that is, the presence of a linear, conjugated pi-system of definite shape and size, have been successfully incorporated into the design of ETB selective polycyclic aromatic sulfonamides antagonists. (C) 1998 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:2301 / 2316
页数:16
相关论文
共 41 条
[1]   CLONING AND EXPRESSION OF A CDNA-ENCODING AN ENDOTHELIN RECEPTOR [J].
ARAI, H ;
HORI, S ;
ARAMORI, I ;
OHKUBO, H ;
NAKANISHI, S .
NATURE, 1990, 348 (6303) :730-732
[2]   New non-peptide endothelin-A receptor antagonists: Synthesis, biological properties, and structure-activity relationships of 5-(dimethylamino)-N-pyridyl-, -N-pyrimidinyl-, -N-pyridazinyl-, and -N-pyrazinyl-1-naphthalenesulfonamides [J].
Bradbury, RH ;
Bath, C ;
Butlin, RJ ;
Dennis, M ;
Heys, C ;
Hunt, SJ ;
James, R ;
Mortlock, AA ;
Sumner, NF ;
Tang, EK ;
Telford, B ;
Whiting, E ;
Wilson, C .
JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (06) :996-1004
[3]   In vitro characterisation of Ro 46-8443, the first non-peptide antagonist selective for the endothelin ET(B) receptor [J].
Breu, V ;
Clozel, M ;
Burri, K ;
Hirth, G ;
Neidhart, W ;
Ramuz, H .
FEBS LETTERS, 1996, 383 (1-2) :37-41
[4]   IDENTIFICATION OF A NEW CLASS OF ET(A) SELECTIVE ENDOTHELIN ANTAGONISTS BY PHARMACOPHORE DIRECTED SCREENING [J].
CHAN, MF ;
OKUN, I ;
STAVROS, FL ;
HWANG, E ;
WOLFF, ME ;
BALAJI, VN .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 201 (01) :228-234
[5]  
Chan MF, 1996, BIOORG MED CHEM LETT, V6, P2393
[6]  
CHAN MF, 1995, 209 NAT M AM CHEM SO
[7]  
CLOZEL M, 1994, J PHARMACOL EXP THER, V270, P228
[8]   PATHOPHYSIOLOGICAL ROLE OF ENDOTHELIN REVEALED BY THE 1ST ORALLY-ACTIVE ENDOTHELIN RECEPTOR ANTAGONIST [J].
CLOZEL, M ;
BREU, V ;
BURRI, K ;
CASSAL, JM ;
FISCHLI, W ;
GRAY, GA ;
HIRTH, G ;
LOFFLER, BM ;
MULLER, M ;
NEIDHART, W ;
RAMUZ, H .
NATURE, 1993, 365 (6448) :759-761
[9]  
CODY WL, 1992, J MED CHEM, V35, P3303
[10]   DISCOVERY OF A NOVEL SERIES OF ORALLY-ACTIVE NONPEPTIDE ENDOTHELIN-A (ET(A)) RECEPTOR-SELECTIVE ANTAGONISTS [J].
DOHERTY, AM ;
PATT, WC ;
EDMUNDS, JJ ;
BERRYMAN, KA ;
REISDORPH, BR ;
PLUMMER, MS ;
SHAHRIPOUR, A ;
LEE, C ;
CHENG, XM ;
WALKER, DM ;
HALEEN, SJ ;
KEISER, JA ;
FLYNN, MA ;
WELCH, KM ;
HALLAK, H ;
TAYLOR, DG ;
REYNOLDS, EE .
JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (08) :1259-1263